ENGOT-ov24-NSGO/AVANOVA
Study documentation (link to documents, only accessible with password to www.nsgo.org). Click HERE for access.
Study sponsor | NSGO |
NSGO Project Manager | Louisa Boufercha +45 3545 3398 |
Study chair | Mansoor Raza Mirza +45 3545 9624 |
Drug | Niraparib and Bevacizumab |
Phase | II |
Randomized trial | Yes |
Type | Open-label |
Total number of patients | 94 patients required |
Number of patients recruited | Recruitment statistics – link |
Trial status | Recruitment closed |
Date of first site activated | 02.03.2016 |
eCRF | Open Clinica test – link (protected information – access only with login) Open Clinica Live – link (protected information – access only with login) |
Site list | Site list – link (protected information – access only with login) |
Protocol summary | ClinicalTrials.gov – link |